Humble

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• Liver cirrhosis2 trials
• Asthma1 trial
• COPD1 trial

Phase

• Phase 34 trials
• Phase 1/21 trial

Status

• Recruiting4 trials
• Completed1 trial

Lead sponsor

• GlaxoSmithKline5 trials

Running trials

• Recruiting

  A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)

  NCT07782996· Phase 3· GlaxoSmithKline· Source

  Contact: Atul Matta (principal investigator)

• Recruiting

  A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

  NCT07780669· Phase 3· GlaxoSmithKline· Source

  Contact: Atul Matta (principal investigator)

• Recruiting

  A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

  NCT07704892· Phase 3· GlaxoSmithKline· Source

  Contact: Brian Chou (principal investigator)

• Recruiting

  A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

  NCT07701993· Phase 3· GlaxoSmithKline· Source

  Contact: Brian Chou (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)2 recruiting
• Liver cirrhosis2 recruiting
• Asthma1 recruiting
• COPD1 recruiting

Closed trials

• Completed

  A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

  NCT05496231· Phase 1/2· GlaxoSmithKline· Source